Pfizer Inc. buy Guggenheim
Start price
11.12.24
/
50%
€24.08
Target price
11.12.25
€31.40
Performance (%)
-6.19%
Price
26.11.25
€22.18
Summary
This prediction is currently active. With a performance of -6.19%, the BUY prediction by Guggenheim is trending in the wrong direction. A total of €0.41 was paid as dividends for this prediction. This prediction currently runs until 11.12.25. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Pfizer Inc. | 2.662% | 2.662% |
| iShares Core DAX® | 2.119% | -1.935% |
| iShares Nasdaq 100 | 1.877% | -0.064% |
| iShares Nikkei 225® | 1.760% | -0.910% |
| iShares S&P 500 | 1.962% | 0.689% |
Comments by Guggenheim for this prediction
In the thread Pfizer Inc. diskutieren
Pfizer Inc. (NYSE: PFE) had its price target lowered by analysts at Guggenheim from $35.00 to $33.00. They now have a "buy" rating on the stock.
Ratings data for PFE provided by MarketBeat